uniQure-UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates

UniQure (QURE) came out with a quarterly loss of $0.91 per share versus the Zacks Consensus Estimate of a loss of$ 1.12. This compares to loss of $1.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 18.75%. A quarter ago, it was expected that this human gene therapy company would post a loss of$ 1.24 per share when it actually produced a loss of $1.16, delivering a surprise of 6.45%.Over the last four quarters, the company ha ...